Abstract:Importance: Earlier administration of intravenous tissue plasminogen activator (tPA) in acute ischemic stroke is associated with reduced mortality by the time of hospital discharge and better functional outcomes at 3 months. However, it remains unclear whether shorter door-to-needle times translate into better long-term outcomes. Objective: To examine whether shorter door-to-needle times with intravenous tPA for acute ischemic stroke are associated with improved long-term outcomes. Design, setting, and participants: This retrospective cohort study included Medicare beneficiaries aged 65 years or older who were treated for acute ischemic stroke with intravenous tPA within 4.5 hours from the time they were last known to be well at Get With The Guidelines-Stroke participating hospitals between January 1, 2006, and December 31, 2016, with 1-year follow-up through December 31, 2017. Exposures: Door-to-needle times for intravenous tPA. Main outcomes and measures: The primary outcomes were 1-year all-cause mortality, all-cause readmission, and the composite of all-cause mortality or readmission. Results: Among the 61 426 patients treated with tPA within 4.5 hours, the median age was 80 years and 43.5% were male. The median door-to-needle time was 65 minutes (interquartile range, 49-88 minutes). The 48 666 patients (79.2%) who were treated with tPA and had door-to-needle times of longer than 45 minutes, compared with those treated within 45 minutes, had significantly higher all-cause mortality (35.0% vs 30.8%, respectively; adjusted HR, 1.13 [95% CI, 1.09-1.18]), higher all-cause readmission (40.8% vs 38.4%; adjusted HR, 1.08 [95% CI, 1.05-1.12]), and higher all-cause mortality or readmission (56.0% vs 52.1%; adjusted HR, 1.09 [95% CI, 1.06-1.12]). The 34 367 patients (55.9%) who were treated with tPA and had door-to-needle times of longer than 60 minutes, compared with those treated within 60 minutes, had significantly higher all-cause mortality (35.8% vs 32.1%, respectively; adjusted hazard ratio [HR], 1.11 [95% CI, 1.07-1.14]), higher all-cause readmission (41.3% vs 39.1%; adjusted HR, 1.07 [95% CI, 1.04-1.10]), and higher all-cause mortality or readmission (56.8% vs 53.1%; adjusted HR, 1.08 [95% CI, 1.05-1.10]). Every 15-minute increase in door-to-needle times was significantly associated with higher all-cause mortality (adjusted HR, 1.04 [95% CI, 1.02-1.05]) within 90 minutes after hospital arrival, but not after 90 minutes (adjusted HR, 1.01 [95% CI, 0.99-1.03]), higher all-cause readmission (adjusted HR, 1.02; 95% CI, 1.01-1.03), and higher all-cause mortality or readmission (adjusted HR, 1.02 [95% CI, 1.01-1.03]). Conclusions and relevance: Among patients aged 65 years or older with acute ischemic stroke who were treated with tissue plasminogen activator, shorter door-to-needle times were associated with lower all-cause mortality and lower all-cause readmission at 1 year. These findings support efforts to shorten time to thrombolytic therapy.

Abstract WP91: Pre-notification Is Associated With Decreased Door To Groin Puncture Time But Not 90-day Modified Rankin Scale

Prehospital Notification Procedure Improves Endovascular Treatment Outcome in Patients with Acute Ischemic Stroke

Prehospital Notification Procedure Improves Stroke Outcome by Shortening Onset to Needle Time in Chinese Urban Area.

[Advanced Treatment Time Improves Outcomes of Patients with Ischemic Stroke Undergoing Reperfusion Therapy].

Acquisition of Prehospital Stroke Severity Scale is associated with shorter door-to-puncture times in patients with prehospital notifications transported directly to a thrombectomy center

Abstract TMP38: Enhancing Door-In-Door-Out Time in a Rural Primary Stroke Center: Early Activation of a Large Vessel Occlusion Alert/Bundle of Care Utilizing EMS Pre-Alert, Parallel System Processing and Auto-Launch of Transfer Resources

Single-step Optimization in Triaging Large Vessel Occlusion Strokes: Identifying Factors to Improve Door-to-groin Time for Endovascular Therapy

Abstract 83: Early Notification Using a Novel Three-Tiered Code Stroke System Reduces Neurointerventional Team Activation Times

Abstract TMP47: Identifying and Categorizing Delays to Endovascular Treatment in Patients With Large Vessel Occlusions

Impact and determinants of door in–door out time for stroke thrombectomy transfers in a large hub-and-spoke network

Abstract WP191: Impact and Determinants of Door In-Door Out Time for Stroke Thrombectomy Transfers: Real World Analysis of a Large Hub-and-Spoke Network

Abstract WMP93: Door-to-Thrombolysis Time Between Primary Stroke Centers and Comprehensive Stroke Centers: Is There an Added Benefit?

Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke

Abstract WMP92: Mode of Onset Modifies the Effect of Time to Endovascular Reperfusion on Clinical Outcomes After Acute Ischemic Stroke: An Analysis of the DAWN Trial

Abstract WP67: Utilization and Impact of Large Vessel Occlusion Stroke Screening Practices and Selected Target Stroke III Strategies in the Get-with-the-Guidelines Registry Hospitals

Effect of the Time from Onset to Recanalization on the Outcomes after Endovascular Treatment in Patients with Acute Stroke Due to Posterior Circulation Large Vessel Occlusion

Abstract WMP36: Quality Improvement for Improved Ischemic Stroke Large Vessel Occlusion Door-In-Door-Out Times at an Urban Primary Stroke Center Integrated Health System

Effect of time delay in inter-hospital transfer on outcomes of endovascular treatment of acute ischemic stroke

Association of Time to Groin Puncture with Patient Outcome after Endovascular Therapy Stratified by Etiology

Abstract WP71: Early Stroke Alert and Telestroke Notification Reduces Door to Needle Time

Some minutes matter more: Groin-to-recanalization is the main time-related predictor of outcome in acute ischemic stroke